Overview

A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the relative bioavailability of nalbuphine after single IM injection of Sebacoyl Dinalbuphine Ester (SDE) injection and BainĀ®, Nalbuphine HCl IM injection in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Lumosa Therapeutics Co., Ltd.
Treatments:
Nalbuphine